Alvotech (ALVOW) Total Non-Current Liabilities (2020 - 2025)
Alvotech (ALVOW) reported Total Non-Current Liabilities of $1.5 billion for Q4 2025, up 1.86% on a YoY basis from $1.4 billion in Q4 2024, and up 1.86% quarter-over-quarter from $1.4 billion in Q3 2025.
Alvotech (ALVOW) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
Alvotech has reported Total Non-Current Liabilities for 6 years, with the latest figure at $1.5 billion in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities rose 1.86% year-over-year to $1.5 billion; the trailing twelve-month figure through Dec 2025 stood at $1.5 billion (up 1.86% YoY), and the FY2025 full-year result was $1.5 billion, up 1.86% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $1.5 billion, up from $1.4 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $1.6 billion in Q4 2023, with the low at $471.9 million in Q2 2024.
- Historically, Total Non-Current Liabilities has averaged $1.2 billion across 5 years, with a median of $1.4 billion in 2023.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities sank 59.58% — and 2025, when it soared 172.57%.
- Alvotech's Total Non-Current Liabilities stood at $621.8 million in 2021, then soared by 97.11% to $1.2 billion in 2022, then soared by 32.32% to $1.6 billion in 2023, then fell by 11.15% to $1.4 billion in 2024, then climbed by 1.86% to $1.5 billion in 2025.
- The last three Total Non-Current Liabilities figures came in at $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.3 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Alvotech | - | - | -22.39 Mn | 1.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.47 Bn |
| Sep 30, 2025 | 1.44 Bn |
| Jun 30, 2025 | 1.29 Bn |
| Mar 31, 2025 | 1.44 Bn |
| Dec 31, 2024 | 1.44 Bn |
| Sep 30, 2024 | 1.42 Bn |
| Jun 30, 2024 | 471.93 Mn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.62 Bn |
| Jun 30, 2023 | 1.17 Bn |
| Mar 31, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Jun 30, 2022 | 792.93 Mn |
| Dec 31, 2021 | 621.75 Mn |
| Dec 31, 2020 | 1.29 Bn |